Cannabis Rescheduling Likely ‘In The Next 12 Months,’ Says MariMed CEO As Company Invests In Key Markets
Senior analyst Pablo Zuanic hosted a fireside chat Monday evening with Jon Levine, CEO of MariMed Inc. (OTC: MRMD) who outlined the company’s operations, growth strategies and financial outlook. The …